Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

125.45 +0.33 (+0.26%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

September 25, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Topics Retirement

Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors ↗

September 24, 2025

Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move.

Via Chartmill

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

Don't Overlook These 2 Dividend Kings in Today's Volatile Market ↗

September 21, 2025

These businesses may be "boring," but that's a good thing in today's market.

Via The Motley Fool

Topics Economy Government World Trade

Navigating the Emotional Tides: Investor Psychology in a Volatile Market

September 22, 2025

The financial markets are currently a tempestuous sea, marked by a perplexing interplay of underlying strength and overt volatility, largely driven by the powerful forces of investor psychology. As of...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

8 Dividend Growth Stocks Every Investor Should Consider ↗

September 19, 2025

These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios.

Via The Motley Fool

Topics Artificial Intelligence Economy

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA ↗

September 18, 2025

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott's Libre 3.

Via Benzinga

September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?

September 15, 2025

As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

3 No-Brainer Dividend Stocks to Buy in September ↗

September 13, 2025

The attraction of these dividend stocks isn't limited to their dividends.

Via The Motley Fool

Topics Intellectual Property

Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock ↗

September 12, 2025

Via Benzinga

3 S&P 500 Stocks to Keep an Eye On

September 12, 2025

The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding...

Via StockStory

Topics Artificial Intelligence Stocks

1 Reason Every Investor Should Know About AbbVie (ABBV) ↗

September 08, 2025

This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.

Via The Motley Fool

Topics Intellectual Property

3 Dividend Stocks to Double Up on Right Now ↗

September 07, 2025

Investors can feel good about upping their bets on these great dividend stocks.

Via The Motley Fool

Topics Energy Intellectual Property

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years? ↗

September 04, 2025

There is more to like than the dividend with these companies.

Via The Motley Fool

Topics Intellectual Property

Peering Into Abbott Laboratories's Recent Short Interest ↗

September 03, 2025

Via Benzinga

5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer ↗

August 31, 2025

Selling these dividend stocks isn't on my radar at all.

Via The Motley Fool

Topics Energy Intellectual Property

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today ↗

August 29, 2025

The company's innovative devices have helped it generate decent performances.

Via The Motley Fool

2 Reasons to Watch ABT and 1 to Stay Cautious

August 28, 2025

Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during...

Via StockStory

Topics Stocks Supply Chain

Navigating the Currents: Top Sectors Primed for Growth in Q3 2025

August 27, 2025

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,...

Via MarketMinute

Topics Artificial Intelligence Economy Retirement

EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big ↗

August 27, 2025

EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost.

Via Benzinga

Topics World Trade

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 23, 2025

Investors will get great dividends and more with these stocks.

Via The Motley Fool

Topics World Trade

2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer ↗

August 21, 2025

These high-yield dividend stocks are built to last.

Via The Motley Fool

Topics Intellectual Property

1 Cash-Producing Stock for Long-Term Investors and 2 We Question

August 19, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

2 Stocks to Buy on the Dip and Hold for 10 Years ↗

August 16, 2025

There should be plenty of long-term upside for these stocks for investors willing to ride out the storm.

Via The Motley Fool

Topics Economy Government

Looking Into Abbott Laboratories's Recent Short Interest ↗

August 15, 2025

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

August 15, 2025

These stocks offer great dividends and more.

Via The Motley Fool

Topics Economy Government World Trade

1 Healthcare Stock for Long-Term Investors and 2 We Ignore

August 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

Recent Filing Shows That Rep. Josh Gottheimer Sold Over $6K Worth of Abbott Laboratories Stock ↗

August 12, 2025

Via Benzinga

3 Stocks Retirees Should Absolutely Love ↗

August 09, 2025

These stocks check off all the boxes for investors no longer receiving a paycheck.

Via The Motley Fool

Topics Economy Retirement

Medical Devices & Supplies - Diversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT)

August 05, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Abbott Laboratories (NYSE:ABT) and its peers.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today